Glenmede Investment Management LP Has $45.31 Million Stock Holdings in Merck & Co., Inc. $MRK

robot
Abstract generation in progress

Glenmede Investment Management LP reduced its stake in Merck & Co., Inc. (NYSE:MRK) by 14.2% in the third quarter, reducing its holdings to 539,875 shares valued at $45.31 million. Other institutional investors also adjusted their positions, and several analysts have recently updated their price targets and ratings for the company, with a consensus rating of “Moderate Buy.” Insiders at Merck & Co., Inc. have sold a significant number of shares recently, while the company reported strong earnings and announced a quarterly dividend.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin